DK0666755T3 - Inhibering af HIV-infektion - Google Patents

Inhibering af HIV-infektion

Info

Publication number
DK0666755T3
DK0666755T3 DK93921439T DK93921439T DK0666755T3 DK 0666755 T3 DK0666755 T3 DK 0666755T3 DK 93921439 T DK93921439 T DK 93921439T DK 93921439 T DK93921439 T DK 93921439T DK 0666755 T3 DK0666755 T3 DK 0666755T3
Authority
DK
Denmark
Prior art keywords
hiv infection
inhibition
slpi
prevention
methods
Prior art date
Application number
DK93921439T
Other languages
Danish (da)
English (en)
Inventor
Stephen Eisenberg
Sharon M Wahl
Robert C Thompson
Original Assignee
Amgen Inc
Us Gov Health & Human Serv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc, Us Gov Health & Human Serv filed Critical Amgen Inc
Application granted granted Critical
Publication of DK0666755T3 publication Critical patent/DK0666755T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • AIDS & HIV (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK93921439T 1992-09-09 1993-09-09 Inhibering af HIV-infektion DK0666755T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94336992A 1992-09-09 1992-09-09
PCT/US1993/008486 WO1994006454A2 (en) 1992-09-09 1993-09-09 Inhibitiion of retrovirus infection

Publications (1)

Publication Number Publication Date
DK0666755T3 true DK0666755T3 (da) 2003-08-04

Family

ID=25479533

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93921439T DK0666755T3 (da) 1992-09-09 1993-09-09 Inhibering af HIV-infektion

Country Status (23)

Country Link
EP (1) EP0666755B1 (pt)
JP (2) JP3517238B2 (pt)
KR (1) KR100273620B1 (pt)
AT (1) ATE238062T1 (pt)
AU (1) AU681350B2 (pt)
CA (1) CA2141951C (pt)
CZ (1) CZ286953B6 (pt)
DE (1) DE69332904T2 (pt)
DK (1) DK0666755T3 (pt)
ES (1) ES2197153T3 (pt)
FI (1) FI951078A0 (pt)
HU (1) HU218892B (pt)
NO (1) NO315546B1 (pt)
NZ (1) NZ256246A (pt)
OA (1) OA10133A (pt)
PL (1) PL307864A1 (pt)
PT (1) PT666755E (pt)
RO (1) RO116164B1 (pt)
RU (1) RU2126266C1 (pt)
SG (1) SG48115A1 (pt)
SK (1) SK281127B6 (pt)
UA (1) UA41338C2 (pt)
WO (1) WO1994006454A2 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9507165A (pt) * 1994-03-23 1997-09-09 Tokyo Tanase Company Limited Inibidor da triptase clara agente terapêutico ou profilático para doenças virais processo terapêutico para doenças virais e uso da antileucoprotease
WO1997003694A1 (fr) * 1995-07-24 1997-02-06 Tokyo Tanabe Company Limited Remede contre les affections virales
EP0861085B1 (en) 1995-11-13 2005-07-20 Vitaleech Bioscience N.V. Anti-viral isolates obtained from leeches
AU780121B2 (en) * 1999-05-13 2005-03-03 Japan Science And Technology Agency Inhibitors for viral infection targeting integrase N-terminal region
DE10101792B4 (de) * 2001-01-17 2004-03-18 Vivotec Biomedical Technologies Gmbh Verfahren zum Nachweis von Pankreaskarzinom oder chronischer Pankreatitis und Verwendung von Antikörpern
WO2005046732A2 (en) 2003-11-04 2005-05-26 THE UNITED SATES OF AMERICA as represented by THE SECRETARY OF HEALTH AND HUMAN SERVICES, NIH Methods and compositions for the inhibition of hiv-1 replication

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1340877C (en) * 1987-12-28 2000-01-18 Takashi Sugiyama Elastase inhibitory polypeptide and process for production thereof by recombinant gene technology
JP2804979B2 (ja) * 1988-11-28 1998-09-30 日本ケミカルリサーチ株式会社 エイズ治療および阻害剤
CA2007083A1 (en) * 1989-01-09 1990-07-09 Nobuhiko Katunuma Pharmaceutical use of trypstatin
JP2930713B2 (ja) * 1989-08-16 1999-08-03 カイロン コーポレイション タンパク質ホルモン形成の抑制用の組成物およびその使用法
AU644621B2 (en) * 1989-12-18 1993-12-16 Transgene S.A. Pharmaceutical composition for treating or preventing retroviral infections
GR1001044B (el) * 1991-06-03 1993-04-28 Logothetou Rella Eleni Μηχανισμός διή?ησης νεοπλασματικών κυττάρων και η χρήση του αναστολέα της Ca2+ -εξαρτώμενης ουδέτερης πρωτεάσης για την παρασκευή φαρμακευτικών αντικαρκινικών συν?έσεων.

Also Published As

Publication number Publication date
JP2004002455A (ja) 2004-01-08
RO116164B1 (ro) 2000-11-30
SG48115A1 (en) 1998-04-17
PL307864A1 (en) 1995-06-26
HU218892B (hu) 2000-12-28
CZ55995A3 (en) 1996-01-17
WO1994006454A3 (en) 1994-08-18
FI951078A (fi) 1995-03-08
DE69332904D1 (de) 2003-05-28
WO1994006454A2 (en) 1994-03-31
EP0666755B1 (en) 2003-04-23
RU2126266C1 (ru) 1999-02-20
KR950703357A (ko) 1995-09-20
NO950897D0 (no) 1995-03-08
NZ256246A (en) 1997-08-22
JP3517238B2 (ja) 2004-04-12
HU9500682D0 (en) 1995-04-28
OA10133A (en) 1996-12-18
CA2141951A1 (en) 1994-03-31
SK29795A3 (en) 1997-02-05
ATE238062T1 (de) 2003-05-15
DE69332904T2 (de) 2003-11-06
NO315546B1 (no) 2003-09-22
FI951078A0 (fi) 1995-03-08
UA41338C2 (uk) 2001-09-17
SK281127B6 (sk) 2000-12-11
AU681350B2 (en) 1997-08-28
EP0666755A1 (en) 1995-08-16
KR100273620B1 (ko) 2000-12-15
RU95109909A (ru) 1997-03-27
JPH08505042A (ja) 1996-06-04
CA2141951C (en) 2007-04-24
AU4853093A (en) 1994-04-12
ES2197153T3 (es) 2004-01-01
NO950897L (no) 1995-03-08
PT666755E (pt) 2003-09-30
CZ286953B6 (en) 2000-08-16
HUT75126A (en) 1997-04-28

Similar Documents

Publication Publication Date Title
DK0793674T3 (da) Inhibitorer af human neutrofil elastase
MX9706913A (es) Compuestos de bis-aminacido-hidroxietilamina-sulfonamida inhibidoresde proteasan retroviral, composiciones que los contienen y ek uso de los mismos.
DK0528858T3 (da) Inhibitorer af dipeptidyl-aminopeptidase type IV
DK0951473T3 (da) Cyclosporinderivat, fremstilling af dette og farmaceutiske præparater indeholdende dette
ES2173341T3 (es) Compuestos inhibidores de proteasa retroviral.
NL300283I1 (nl) Alfa- en bèta-aminozuur-hydroxyethylamino-sulfonamiden die toepasbaar zijn als retrovirale-prothease-remmers.
NO932620L (no) Amindiol-proteaseinhibitorer
EA199700222A1 (ru) Сульфонилалканоиламиногидроксиэтиламиносульфонамид в качестве ингибиторов ретровирусной протеазы
EE04349B1 (et) Aminohappe hüdroksüetüülamino-sulfoonamiidsed retroviirusliku proteaasi inhibiitorid
NO983688L (no) Serin-protease-inhibitorer
DK0815124T3 (da) Heterocyckliske carbonylaminosyre-hydroxyethylamino-sulfonamidinhibitorer af retrovirale proteaser
NO962017L (no) 5,6-Dihydropyron - derivater som protease-inhibitorer og antivirus-midler
NO983991L (no) Serin-protease-inhibitorer
MD960172A (en) 5,6-dihydropyrone derivatives as proteaze inhibitors and antiviral agents
DK0666755T3 (da) Inhibering af HIV-infektion
DK0817624T3 (da) Inhibitorer af metazoparasitproteaser
EE9900188A (et) HIV proteaasi inhibiitoritena kasulikud 1-(3-aminoindasool-5-üül)-3-fenüülmetüül-tsüklilised uuread
MX9304351A (es) Inhibidores de proteasas de aminodiol y composiciones farmaceuticas que los incluyen.
MX9706912A (es) Inhibidores de protesa retroviral de sulfonamida de hidroxietilamino de amino acido y uso de los mismos.